Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males

Objectives The aim of the study was to determine the prevalence of abnormal cytological findings, high risk (HR)-HPV genotypes and to identify factors associated with an abnormal cytological findings in a cohort of HIV-infected males. Patients and methods Retrospective observational study on HIV-infected male patients who performed screening in the absence of clinical symptoms. Cytological abnormalities were classified as atypical squamous cells of undetermined significance (ASC-US), low-grade(LSIL) or high high-grade squamous intraepithelial lesion (HSIL). Logistic regression models were used to identify predictors of having LSIL/HSIL. Results Among 875 pts, abnormal cytology findings were observed in 254 (29%, 95% CI: 26.1%-32.1%) subjects: 142 (16%) had LSIL and 49 (6%) HSIL. Overall, 581 (66%, 95%CI: 63.2%-69.5%) subjects had ≥1 HR-HPV type and 269 (31%) had ≥2 HR HPV types. Multivariate logistic regression showed that subjects with multiple HR-HPV genotypes (OR = 1.351, 95%CI: 1.005–2.111) and with HPV-16 type (OR = 2.032, 95%CI: 1.313–3.146) were more likely to have LSIL/HSIL in addition to a lower CD4+/CD8+ ratio, a previous diagnosis of syphilis and a positive viral load. In another multivariate model, the presence of multiple HPV types in subjects with HPV-16 type was associated with the highest adjusted OR of having a LSIL/HSIL (OR = 2.598, 95%CI: 1.460–4.624). Conclusions In HIV-infected men, the prevalence of abnormal cytological findings was of 29% and of HR-HPV was 66%. The concomitant presence of HPV-16 and multiple HR genotypes was associated with an increased risk of abnormal cytological findings. These data highlight the importance of screening multiple HPV genotypes in HIV-infected patients.

[1]  T. Huang,et al.  Deep sequencing of HPV E6/E7 genes reveals loss of genotypic diversity and gain of clonal dominance in high-grade intraepithelial lesions of the cervix , 2017, BMC Genomics.

[2]  J. McIntyre,et al.  The prevalence of human papillomavirus infections and associated risk factors in men-who-have-sex-with-men in Cape Town, South Africa , 2016, BMC Infectious Diseases.

[3]  J. Mossong,et al.  Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples. , 2016, Diagnostic microbiology and infectious disease.

[4]  A. Kreuter,et al.  The male ScreenING Study: prevalence of HPV‐related genital and anal lesions in an urban cohort of HIV‐positive men in Germany , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  H. Kitchener,et al.  A prospective study of anal cancer screening in HIV-positive and negative MSM , 2016, AIDS.

[6]  M. Capobianchi,et al.  An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infections. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  S. Oka,et al.  Prevalence of Anal Human Papillomavirus Infection and Risk Factors among HIV-positive Patients in Tokyo, Japan , 2015, PloS one.

[8]  A. d’Arminio Monforte,et al.  CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. , 2015, The lancet. HIV.

[9]  J. Nachega,et al.  Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV , 2015, AIDS.

[10]  W. Quint,et al.  One lesion, one virus: individual components of high-grade anal intraepithelial neoplasia in HIV-positive men contain a single HPV type. , 2014, The Journal of infectious diseases.

[11]  Ross D. Cranston,et al.  Progression of anal high‐grade squamous intraepithelial lesions to invasive anal cancer among HIV‐infected men who have sex with men , 2014, International journal of cancer.

[12]  R. Sahli,et al.  Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV Assay for Human Papillomavirus Genotyping , 2013, Journal of Clinical Microbiology.

[13]  B. Hernández-Novoa,et al.  Anal squamous intraepithelial lesions are frequent among young HIV‐infected men who have sex with men followed up at the Spanish AIDS Research Network Cohort (CoRIS‐HPV) , 2013, International journal of cancer.

[14]  S. Vermund,et al.  Anal Human Papillomavirus Infection Among HIV-Infected and Uninfected Men Who Have Sex With Men in Beijing, China , 2013, Journal of acquired immune deficiency syndromes.

[15]  J. del Romero,et al.  Anal Human Papillomavirus Genotype Distribution in HIV-Infected Men Who Have Sex with Men by Geographical Origin, Age, and Cytological Status in a Spanish Cohort , 2013, Journal of Clinical Microbiology.

[16]  P. Castle,et al.  Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. , 2013, The Journal of infectious diseases.

[17]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[18]  J. Goedert,et al.  Spectrum of AIDS-associated malignant disorders , 1998, The Lancet.

[19]  J. Palefsky,et al.  Anal neoplasia. Pathogenesis, diagnosis, and management. , 1996, Hematology/oncology clinics of North America.

[20]  J. Palefsky,et al.  Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. , 1994, Journal of acquired immune deficiency syndromes.